Toggle navigation
About
Abstract
Editorial Board
Subscription & Newsletter
Contact
Issues
This issue
23-3
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
23-3
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #81295
advertisement
Terao E
13
Showing records 1 to 13 |
Display all abstracts from
Terao E
106950
Efficacy and safety of a fixed combination of 1% brinzolamide and 0.1% brimonidine as treatment for glaucoma: a retrospective study focusing on the number of ingredients
Aoki R
BMJ open ophthalmology
2022; 7:
106376
Effect of idiopathic epiretinal membrane on macular ganglion cell complex measurement in eyes with glaucoma
Nakakura S
Frontiers in medicine
2022; 9: 972962
106950
Efficacy and safety of a fixed combination of 1% brinzolamide and 0.1% brimonidine as treatment for glaucoma: a retrospective study focusing on the number of ingredients
Terao E
BMJ open ophthalmology
2022; 7:
106376
Effect of idiopathic epiretinal membrane on macular ganglion cell complex measurement in eyes with glaucoma
Asaoka R
Frontiers in medicine
2022; 9: 972962
106950
Efficacy and safety of a fixed combination of 1% brinzolamide and 0.1% brimonidine as treatment for glaucoma: a retrospective study focusing on the number of ingredients
Dote S
BMJ open ophthalmology
2022; 7:
106376
Effect of idiopathic epiretinal membrane on macular ganglion cell complex measurement in eyes with glaucoma
Oogi S; Aoki R
Frontiers in medicine
2022; 9: 972962
106950
Efficacy and safety of a fixed combination of 1% brinzolamide and 0.1% brimonidine as treatment for glaucoma: a retrospective study focusing on the number of ingredients
Shiraishi M; Oogi S
BMJ open ophthalmology
2022; 7:
106376
Effect of idiopathic epiretinal membrane on macular ganglion cell complex measurement in eyes with glaucoma
Terao E
Frontiers in medicine
2022; 9: 972962
106950
Efficacy and safety of a fixed combination of 1% brinzolamide and 0.1% brimonidine as treatment for glaucoma: a retrospective study focusing on the number of ingredients
Ueda K
BMJ open ophthalmology
2022; 7:
106376
Effect of idiopathic epiretinal membrane on macular ganglion cell complex measurement in eyes with glaucoma
Ueda K
Frontiers in medicine
2022; 9: 972962
106950
Efficacy and safety of a fixed combination of 1% brinzolamide and 0.1% brimonidine as treatment for glaucoma: a retrospective study focusing on the number of ingredients
Kimura Y
BMJ open ophthalmology
2022; 7:
106376
Effect of idiopathic epiretinal membrane on macular ganglion cell complex measurement in eyes with glaucoma
Kiuchi Y
Frontiers in medicine
2022; 9: 972962
106950
Efficacy and safety of a fixed combination of 1% brinzolamide and 0.1% brimonidine as treatment for glaucoma: a retrospective study focusing on the number of ingredients
Nagata Y; Nakakura S
BMJ open ophthalmology
2022; 7:
Issue
23-3
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept